{"date":"2025-03-07","count":41,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6662-2025-03-07-1958-lfcvz2","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2025-03-07","time":"19:58:56","subject":"公告本公司發言人、財務主管、會計主管及公司治理主管異動","clause":"第8款","fact_date":"2025-03-07","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2025-03-07 19:58，「公告本公司發言人、財務主管、會計主管及公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2025-03-07-1956-p8zct7","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2025-03-07","time":"19:56:11","subject":"本公司董事會決議召開114年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2025-03-07 19:56，「本公司董事會決議召開114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2025-03-07-1953-1dmhjg9","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2025-03-07","time":"19:53:12","subject":"董事會決議股利分派及資本公積發放現金","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2025-03-07 19:53，「董事會決議股利分派及資本公積發放現金」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2025-03-07-1943-1hsk3vq","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2025-03-07","time":"19:43:50","subject":"公告本公司董事會決議通過113年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2025-03-07 19:43，「公告本公司董事會決議通過113年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2025-03-07-1822-10554si","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2025-03-07","time":"18:22:45","subject":"公告本公司董事會決議盈餘及資本公積分配情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2025-03-07 18:22，「公告本公司董事會決議盈餘及資本公積分配情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-03-07-1804-1f00jr6","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-03-07","time":"18:04:52","subject":"本公司受邀參加元大證券舉辦之英文線上法人座談會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-03-07 18:04，「本公司受邀參加元大證券舉辦之英文線上法人座談會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-03-07-1804-c2h6ra","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-03-07","time":"18:04:13","subject":"本公司受邀參加元大證券舉辦之中文線上法人座談會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-03-07 18:04，「本公司受邀參加元大證券舉辦之中文線上法人座談會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2025-03-07-1739-1jqlr5o","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2025-03-07","time":"17:39:52","subject":"公告本公司董事會通過113年第4季合併財務報告","clause":"第31款","fact_date":"2025-03-07","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2025-03-07 17:39，「公告本公司董事會通過113年第4季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2025-03-07-1738-1g7c29d","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2025-03-07","time":"17:38:24","subject":"公告本公司董事會決議召開114年股東常會事宜","clause":"第17款","fact_date":"2025-03-07","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2025-03-07 17:38，「公告本公司董事會決議召開114年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2025-03-07-1733-1v3xp9t","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2025-03-07","time":"17:33:55","subject":"公告本公司董事會決議113年度股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2025-03-07 17:33，「公告本公司董事會決議113年度股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2025-03-07-1733-1hku5w3","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2025-03-07","time":"17:33:36","subject":"公告本公司董事會通過113年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2025-03-07 17:33，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2025-03-07-1729-aibvtt","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2025-03-07","time":"17:29:30","subject":"公告本公司申請新增劑型(注射液劑(無菌製備-小容量))與擴建無菌產線(1棟4樓自動無菌充填產線)GMP查核，已獲衛福部許可。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2025-03-07 17:29，「公告本公司申請新增劑型(注射液劑(無菌製備-小容量))與擴建無菌產線(1棟4樓自動無菌充填產線)GMP查核，已獲衛福部許」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4911-2025-03-07-1720-11wjw0o","company_id":"4911","company":"德英","market":"上櫃","industry":"生技醫療","date":"2025-03-07","time":"17:20:45","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：德英（4911），2025-03-07 17:20，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2025-03-07-1718-1wj6dql","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2025-03-07","time":"17:18:30","subject":"本公司董事會決議召開114年股東常會事宜(新增報告及討論事項)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2025-03-07 17:18，「本公司董事會決議召開114年股東常會事宜(新增報告及討論事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2025-03-07-1649-11wjw0o","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2025-03-07","time":"16:49:00","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2025-03-07 16:49，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2025-03-07-1648-1kabl4o","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2025-03-07","time":"16:48:22","subject":"公告本公司董事會通過向關係人取得使用權資產","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2025-03-07 16:48，「公告本公司董事會通過向關係人取得使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2025-03-07-1642-tulf6t","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2025-03-07","time":"16:42:45","subject":"公告本公司董事會決議召開114年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2025-03-07 16:42，「公告本公司董事會決議召開114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2025-03-07-1642-1ct8byn","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2025-03-07","time":"16:42:22","subject":"公告本公司113年度財務報告業經提報董事會通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2025-03-07 16:42，「公告本公司113年度財務報告業經提報董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2025-03-07-1622-s364tb","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2025-03-07","time":"16:22:25","subject":"公告本公司訂定除息基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2025-03-07 16:22，「公告本公司訂定除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2025-03-07-1621-p67uuk","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2025-03-07","time":"16:21:36","subject":"公告本公司內部稽核主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2025-03-07 16:21，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2025-03-07-1616-xxbxjl","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2025-03-07","time":"16:16:35","subject":"公告本公司受邀參加華南永昌證券舉辦之投資論壇","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2025-03-07 16:16，「公告本公司受邀參加華南永昌證券舉辦之投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4911-2025-03-07-1612-a4n3im","company_id":"4911","company":"德英","market":"上櫃","industry":"生技醫療","date":"2025-03-07","time":"16:12:09","subject":"公告本公司董事會決議113年度盈餘轉增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：德英（4911），2025-03-07 16:12，「公告本公司董事會決議113年度盈餘轉增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4911-2025-03-07-1611-1pb8ufa","company_id":"4911","company":"德英","market":"上櫃","industry":"生技醫療","date":"2025-03-07","time":"16:11:20","subject":"公告本公司董事會決議召開114年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：德英（4911），2025-03-07 16:11，「公告本公司董事會決議召開114年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4911-2025-03-07-1610-1dmdgdo","company_id":"4911","company":"德英","market":"上櫃","industry":"生技醫療","date":"2025-03-07","time":"16:10:48","subject":"公告本公司董事會通過113年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：德英（4911），2025-03-07 16:10，「公告本公司董事會通過113年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2025-03-07-1604-1u7pahz","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2025-03-07","time":"16:04:51","subject":"董事會決議不分派股利","clause":"第31款","fact_date":"2025-03-07","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2025-03-07 16:04，「董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2025-03-07-1603-1ti5er1","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2025-03-07","time":"16:03:11","subject":"本公司董事會決議114年第一季起更換簽證會計師","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2025-03-07 16:03，「本公司董事會決議114年第一季起更換簽證會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2025-03-07-1601-13tl3ny","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2025-03-07","time":"16:01:51","subject":"本公司董事會決議虧損撥補及不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2025-03-07 16:01，「本公司董事會決議虧損撥補及不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2025-03-07-1601-hwnmbx","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2025-03-07","time":"16:01:21","subject":"公告本公司董事會決議召開114年股東常會及國內轉換公司債停止轉換期間","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2025-03-07 16:01，「公告本公司董事會決議召開114年股東常會及國內轉換公司債停止轉換期間」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2025-03-07-1559-1qnfv89","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2025-03-07","time":"15:59:29","subject":"公告本公司董事會通過113年度合併財務報表","clause":"第43款","fact_date":"2025-03-07","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2025-03-07 15:59，「公告本公司董事會通過113年度合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2025-03-07-1559-16mz5e4","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2025-03-07","time":"15:59:16","subject":"公告本公司董事會通過財務主管暨公司治理主管、代理發言人、會計主管、稽核主管異動追認案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2025-03-07 15:59，「公告本公司董事會通過財務主管暨公司治理主管、代理發言人、會計主管、稽核主管異動追認案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2025-03-07-1559-oj50r8","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2025-03-07","time":"15:59:02","subject":"公告本公司董事會決議114年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2025-03-07 15:59，「公告本公司董事會決議114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2025-03-07-1558-1v1wt8s","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2025-03-07","time":"15:58:54","subject":"公告本公司取得會計師113年度內部控制專案審查報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2025-03-07 15:58，「公告本公司取得會計師113年度內部控制專案審查報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2025-03-07-1557-1hku5w3","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2025-03-07","time":"15:57:32","subject":"公告本公司董事會通過113年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2025-03-07 15:57，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2025-03-07-1555-p9bs5i","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2025-03-07","time":"15:55:58","subject":"公告本公司重要營運主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2025-03-07 15:55，「公告本公司重要營運主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2025-03-07-1547-5rax5d","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2025-03-07","time":"15:47:23","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2025-03-07 15:47，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2025-03-07-1545-tulf6t","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2025-03-07","time":"15:45:41","subject":"公告本公司董事會決議召開114年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2025-03-07 15:45，「公告本公司董事會決議召開114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2025-03-07-1528-1lmkr4l","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2025-03-07","time":"15:28:16","subject":"本公司第六次買回公司股份期間屆滿及執行狀況","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2025-03-07 15:28，「本公司第六次買回公司股份期間屆滿及執行狀況」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-03-07-1526-1pymrg6","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-03-07","time":"15:26:13","subject":"公告本公司114年第一次股東臨時會通過解除董事競業禁止限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-03-07 15:26，「公告本公司114年第一次股東臨時會通過解除董事競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-03-07-1525-wj9xas","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-03-07","time":"15:25:59","subject":"公告本公司114年第一次股東臨時會董事當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-03-07 15:25，「公告本公司114年第一次股東臨時會董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-03-07-1525-ub84r7","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-03-07","time":"15:25:35","subject":"公告本公司114年第一次股東臨時會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-03-07 15:25，「公告本公司114年第一次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1789-2025-03-07-1404-xa6c64","company_id":"1789","company":"神隆","market":"上市","industry":"生技醫療","date":"2025-03-07","time":"14:04:49","subject":"公告台灣神隆股份有限公司舉行2024全年法人說明會","clause":"第12款","fact_date":"2025-03-13","cite_as":"公開資訊觀測站重大訊息：神隆（1789），2025-03-07 14:04，「公告台灣神隆股份有限公司舉行2024全年法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}